Literature DB >> 12077208

Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

Shannon E Burgess1, Luis R Gardell, Michael H Ossipov, T Philip Malan, Todd W Vanderah, Josephine Lai, Frank Porreca.   

Abstract

Although injury-induced afferent discharge declines significantly over time, experimental neuropathic pain persists unchanged for long periods. These observations suggest that processes that initiate experimental neuropathic pain may differ from those that maintain such pain. Here, the role of descending facilitation arising from developing plasticity in the rostral ventromedial medulla (RVM) in the initiation and maintenance of experimental neuropathic pain was explored. Tactile and thermal hypersensitivity were induced in rats by spinal nerve ligation (SNL). RVM lidocaine blocked SNL-induced tactile and thermal hypersensitivity on post-SNL days 6-12 but not on post-SNL day 3. Lesion of RVM cells expressing mu-opioid receptors with dermorphin-saporin did not prevent the onset of SNL-induced tactile and thermal hypersensitivity, but these signs reversed to baseline levels beginning on post-SNL day 4. Similarly, lesions of the dorsolateral funiculus (DLF) did not prevent the onset of SNL-induced tactile and thermal hypersensitivity, but these signs reversed to baseline levels beginning on post-SNL day 4. Lesions of the DLF also blocked the SNL-induced increase in spinal dynorphin content, which has been suggested to promote neuropathic pain. These data distinguish mechanisms that initiate the neuropathic state as independent of descending supraspinal influences and additional mechanism(s) that require supraspinal facilitation to maintain such pain. In addition, the data indicate that these time-dependent descending influences can underlie some of the SNL-induced plasticity at the spinal level. Such time-dependent descending influences driving associated spinal changes, such as the upregulation of dynorphin, are key elements in the maintenance, but not initiation, of neuropathic states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077208      PMCID: PMC6757729     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  101 in total

1.  WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression.

Authors:  G T Whiteside; J M Dwyer; J E Harrison; C E Beyer; T Cummons; L Manzino; L Mark; G H Johnston; B W Strassle; A Adedoyin; P Lu; M J Piesla; C M Pulicicchio; J C L Erve; B J Platt; Z A Hughes; K E Rogers; D C Deecher; E J Trybulski; J D Kennedy; P Zhang; L Leventhal
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

2.  Effects of chronic constriction injury and spared nerve injury, two models of neuropathic pain, on the numbers of neurons and glia in the rostral ventromedial medulla.

Authors:  Mai Lan Leong; Rebecca Speltz; Martin Wessendorf
Journal:  Neurosci Lett       Date:  2016-02-06       Impact factor: 3.046

3.  Control of chronic pain by the ubiquitin proteasome system in the spinal cord.

Authors:  Michael H Ossipov; Igor Bazov; Luis R Gardell; Justin Kowal; Tatiana Yakovleva; Ivan Usynin; Tomas J Ekström; Frank Porreca; Georgy Bakalkin
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 4.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

5.  Substance P enhances excitatory synaptic transmission on spinally projecting neurons in the rostral ventromedial medulla after inflammatory injury.

Authors:  Liang Zhang; Donna L Hammond
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

Review 6.  Epigenetic mechanisms of chronic pain.

Authors:  Giannina Descalzi; Daigo Ikegami; Toshikazu Ushijima; Eric J Nestler; Venetia Zachariou; Minoru Narita
Journal:  Trends Neurosci       Date:  2015-03-09       Impact factor: 13.837

Review 7.  Pain and analgesia: the value of salience circuits.

Authors:  David Borsook; Robert Edwards; Igor Elman; Lino Becerra; Jon Levine
Journal:  Prog Neurobiol       Date:  2013-03-07       Impact factor: 11.685

Review 8.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

9.  Role of RVM neurons in capsaicin-evoked visceral nociception and referred hyperalgesia.

Authors:  Raul Sanoja; Victor Tortorici; Carlos Fernandez; Theodore J Price; Fernando Cervero
Journal:  Eur J Pain       Date:  2009-05-13       Impact factor: 3.931

10.  Unmasking the tonic-aversive state in neuropathic pain.

Authors:  Tamara King; Louis Vera-Portocarrero; Tannia Gutierrez; Todd W Vanderah; Gregory Dussor; Josephine Lai; Howard L Fields; Frank Porreca
Journal:  Nat Neurosci       Date:  2009-09-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.